Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Collagen density regulates the activity of tumor-infiltrating T cells.

Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbæk MS, Simões AMC, Roslind A, Engelholm LH, Noessner E, Donia M, Svane IM, Straten PT, Grøntved L, Madsen DH.

J Immunother Cancer. 2019 Mar 12;7(1):68. doi: 10.1186/s40425-019-0556-6.

2.

PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review.

Stovgaard ES, Dyhl-Polk A, Roslind A, Balslev E, Nielsen D.

Breast Cancer Res Treat. 2019 Apr;174(3):571-584. doi: 10.1007/s10549-019-05130-1. Epub 2019 Jan 10. Review.

PMID:
30627961
3.

Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial.

Langhans L, Tvedskov TF, Klausen TL, Jensen MB, Talman ML, Vejborg I, Benian C, Roslind A, Hermansen J, Oturai PS, Bentzon N, Kroman N.

Ann Surg. 2017 Jul;266(1):29-35. doi: 10.1097/SLA.0000000000002101.

PMID:
28257326
4.

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.

Schultz NA, Werner J, Willenbrock H, Roslind A, Giese N, Horn T, Wøjdemann M, Johansen JS.

Mod Pathol. 2012 Dec;25(12):1609-22. doi: 10.1038/modpathol.2012.122. Epub 2012 Aug 10.

5.

Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index.

Schultz NA, Andersen KK, Roslind A, Willenbrock H, Wøjdemann M, Johansen JS.

World J Surg. 2012 Nov;36(11):2699-707. doi: 10.1007/s00268-012-1705-y.

PMID:
22851141
6.

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.

Schultz NA, Roslind A, Christensen IJ, Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann M, Johansen JS.

Pancreas. 2012 Jul;41(5):759-66. doi: 10.1097/MPA.0b013e31823cd9df.

PMID:
22699145
7.

[Signet ring cell carcinoma of the gallbladder].

Agergaard Thing B, Roslind A, Wøjdemann M.

Ugeskr Laeger. 2012 Apr 2;174(14):948-9. Danish.

PMID:
22469166
8.

YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis.

Richter B, Roslind A, Hesse U, Nordling J, Johansen JS, Horn T, Hansen AB.

Histopathology. 2010 Sep;57(3):371-83. doi: 10.1111/j.1365-2559.2010.03640.x.

PMID:
20840668
9.

Supraclavicular recurrence after early breast cancer: a curable condition?

Pedersen AN, Møller S, Steffensen KD, Haahr V, Jensen M, Kempel MM, Jepsen SL, Madsen EL, Roslind A, Sandberg E, Schöllkopf C, Sørensen PG, Windfeldt KM, Andersson M.

Breast Cancer Res Treat. 2011 Feb;125(3):815-22. doi: 10.1007/s10549-010-0918-8. Epub 2010 May 8.

PMID:
20454924
10.

YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.

Roslind A, Johansen JS.

Methods Mol Biol. 2009;511:159-84. doi: 10.1007/978-1-59745-447-6_7.

PMID:
19347297
11.

Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast.

Roslind A, Balslev E, Kruse H, Staergaard B, Horn T.

Ultrastruct Pathol. 2008 May-Jun;32(3):101-6. doi: 10.1080/01913120801937673.

PMID:
18570155
12.

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.

Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen DL, Price PA, Balslev E.

Breast Cancer Res Treat. 2008 Nov;112(2):275-85. Epub 2007 Dec 22.

PMID:
18157633
13.

YKL-40 expression in benign and malignant lesions of the breast: a methodologic study.

Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E.

Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):371-81.

PMID:
18091378
14.

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.

Roslind A, Johansen JS, Christensen IJ, Kiss K, Balslev E, Nielsen DL, Bentzen J, Price PA, Andersen E.

Int J Cancer. 2008 Feb 15;122(4):857-63.

15.

Contrast kinetics of the malignant breast tumour--border versus centre enhancement on dynamic midfield MRI.

Marklund M, Torp-Pedersen S, Bentzon N, Thomsen C, Roslind A, Nolsøe CP.

Eur J Radiol. 2008 Feb;65(2):279-85. Epub 2007 Apr 27.

PMID:
17467219
16.

Is YKL-40 a new therapeutic target in cancer?

Johansen JS, Jensen BV, Roslind A, Price PA.

Expert Opin Ther Targets. 2007 Feb;11(2):219-34. Review.

PMID:
17227236
17.

Serum YKL-40, a new prognostic biomarker in cancer patients?

Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. Review.

Supplemental Content

Loading ...
Support Center